Drug intelligence / Profile preview

full-length human dystrophin

Development stage
Unknown
Modality
Recombinant Proteins and Enzymes, Gene Therapies
Administration
Intramuscular
01

Overview

Full-length human dystrophin is a large sarcolemmal protein crucial for maintaining muscle membrane integrity. Mutations in the dystrophin gene cause Duchenne muscular dystrophy (DMD), an X-linked recessive disorder characterized by progressive muscle degeneration. Due to its substantial size (2.4 Mb gene, >11 kb cDNA, 427 kDa protein), delivering the full-length dystrophin gene for therapeutic purposes presents significant challenges for gene therapy. Various approaches, including human artificial chromosomes (HACs), piggyBac transposons, and adeno-associated viral (AAV) vectors, are being explored to enable its expression in muscle cells to ameliorate DMD phenotypes.

02

Targets

DTN (Dystrobrevin)NOS1 (nNOS)SNT (Syntrophin)F-actin (Filamentous actin)DAG1 (Dystroglycan 1)

Beyond the preview

Go deeper on full-length human dystrophin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on full-length human dystrophin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call